News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,437 Results
Type
Article (8036)
Company Profile (140)
Press Release (476356)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166738)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238191)
Policy (17898)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33161)
ALS (104)
Alzheimer's disease (974)
Antibody-drug conjugate (ADC) (262)
Approvals (10369)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6963)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (507)
Cancer (3628)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47849)
Collaboration (1239)
Commercialization (3)
Compensation (1449)
Complete response letters (34)
COVID-19 (756)
CRISPR (63)
C-suite (737)
Cystic fibrosis (85)
Data (5626)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4178)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73675)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87591)
Executive appointments (698)
FDA (12368)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (910)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (950)
Grass and pollen (2)
Guidances (281)
Healthcare (9326)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (156)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (528)
Marketing (8)
MASH (118)
Medical device (8650)
Medtech (8790)
Mergers & acquisitions (14379)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1818)
NextGen: Class of 2026 (3153)
Non-profit (846)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41227)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15459)
Phase 2 (21369)
Phase 3 (14391)
Pipeline (7236)
Policy (18)
Postmarket research (1572)
Preclinical (6537)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3021)
Recruiting (6)
Regulatory (14801)
Reports (20)
Research institute (582)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Last 7 days (457)
Last 30 days (1606)
Last 365 days (19025)
2026 (12075)
2025 (19251)
2024 (22988)
2023 (26541)
2022 (34587)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17468)
2017 (18765)
2016 (17920)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17879)
Australia (2097)
California (11905)
Canada (3127)
China (517)
Colorado (481)
Connecticut (407)
Delaware (207)
Europe (24615)
Florida (1780)
Georgia (375)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1193)
Massachusetts (7825)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2610)
New Mexico (12)
New York (2811)
North Carolina (1267)
North Dakota (4)
Northern California (5961)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2244)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4942)
Tennessee (119)
Texas (1925)
United States (38673)
Utah (358)
Vermont (1)
Virginia (152)
Washington D.C. (38)
Washington State (921)
West Virginia (1)
Wisconsin (73)
484,437 Results for "valgenesis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ValGenesis Strengthens Presence in Japan with Validator K.K. Partnership
April 1, 2026
·
3 min read
Press Releases
LOTTE Biologics Implements ValGenesis e-Logbook Solution to Modernize QC Operations
March 17, 2026
·
3 min read
Press Releases
ValGenesis to Showcase Process Lifecycle Suite at BioProcessing Summit Europe 2026
March 2, 2026
·
1 min read
Press Releases
ValGenesis to Join Industry Peers at 2026 ISPE San Francisco Vendor Night
February 26, 2026
·
1 min read
Press Releases
ValGenesis to Showcase AI-Enabled Validation at 2025 ISPE Annual Meeting and Expo
October 23, 2025
·
3 min read
Biotech Bay
AmplifyBio Goes Live with ValGenesis VLMS
ValGenesis, Inc. announced that AmplifyBio, a rapidly growing contract research organization, successfully went live with the ValGenesis validation lifecycle management system to efficiently manage digital validation processes.
December 12, 2023
·
4 min read
Biotech Bay
ValGenesis and Célere Partner to Serve Life Sciences Companies in the U.S. and Europe
ValGenesis Inc. and Célere have partnered to deliver best-in-class digital validation solutions for companies across the U.S. and Europe.
June 11, 2024
·
3 min read
Biotech Bay
Leading Global Biotechnology Company Selects ValGenesis iRisk to Advance Its Pipeline of Critical Drug Therapies
ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a leading global biotechnology company selected ValGenesis iRisk to digitalize the quality risk management processes across its manufacturing sites.
April 16, 2024
·
2 min read
Biotech Bay
ValGenesis Unveils VLMS 5.0, Revolutionizing Digital Validation with Industry-First AI Innovation
ValGenesis Inc. announced the launch of VLMS 5.0, the revolutionary new version of its flagship digital validation lifecycle management software poised to transform the industry’s approach to digital transformation.
June 4, 2024
·
3 min read
Biotech Bay
Japanese Multinational Biopharmaceutical Company Selects ValGenesis iRisk for Implementing ICH Q14 Framework
ValGenesis, Inc. announced that a Japanese multinational biopharmaceutical company selected ValGenesis iRisk for implementing the ICH Q14 framework on Process Analytical Technology analytical methods across its global manufacturing sites.
March 12, 2024
·
2 min read
1 of 48,444
Next
